Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Lack of a certain enzyme causes hair to grey early by damaging stem cells, but an antioxidant can help prevent this.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

RIPK1 inhibitors might help prevent alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

CRF can cause hair loss, but blocking its receptors might prevent this.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Green tea's EGCG has various health benefits, including antioxidant properties, skin protection, cancer cell growth inhibition, anti-inflammatory effects, fat breakdown, detoxification, diabetes management, hair growth stimulation, and prevention of gum disease.

New and repurposed treatments are improving outcomes in dermatology.

EGF controls hair growth by regulating hair follicles' growth phases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Changing YBX1 protein activity affects skin stem cell function and aging.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.